Key Insights

Highlights

Success Rate

80% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 37/100

Termination Rate

11.1%

1 terminated out of 9 trials

Success Rate

80.0%

-6.5% vs benchmark

Late-Stage Pipeline

22%

2 trials in Phase 3/4

Results Transparency

75%

3 of 4 completed with results

Key Signals

3 with results80% success

Data Visualizations

Phase Distribution

8Total

Not Applicable (5)

P 2 (1)

P 4 (2)

Trial Status

Completed4

Recruiting3

Terminated1

Active Not Recruiting1

Trial Success Rate

80.0%

Benchmark: 86.5%

Based on 4 completed trials

Clinical Trials (9)

Showing 9 of 9 trials

NCT07253532Not ApplicableRecruiting

Vibrotactile Balance Belt Effect on Improving Gait

NCT07471919Not ApplicableRecruiting

Robot-Assisted Gait Training vs Visual Feedback Balance Training in Stroke

NCT04469959Phase 2Active Not Recruiting

Dopaminergic Dysfunction in Late-Life Depression

NCT03666533Not ApplicableCompleted

Transcranial Direct Current Stimulation for Post-stroke Gait Rehab

NCT06939660Not ApplicableRecruiting

BCI-Assisted SCS-EXS for Gait Optimization

NCT01002586Not ApplicableCompleted

Wii-Fit For Improving Activity, Gait And Balance In Alzheimer's Dementia

NCT04493320Phase 4Terminated

1/2-Dopaminergic Dysfunction in Late-Life Depression (The D3 Study)

NCT04202991Completed

The Relationship Between Pain, Balance and Gait in People With Chronic Obstructive Pulmonary Disease

NCT00526630Phase 4Completed

Methylphenidate for the Treatment of Gait Impairment in Parkinson's Disease

Showing all 9 trials

Gait Impairment